You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 296 No. 22, December 13, 2006 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Aging/ Geriatrics
 •Men's Health
 •Prostate Disease
 •Oncology
 •Prostate Cancer
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Treating Older Men With Prostate Cancer

Survival (or Selection) of the Fittest?

Mark S. Litwin, MD, MPH; David C. Miller, MD, MPH

JAMA. 2006;296:2733-2734.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Recent declines in cause-specific mortality rates among men with prostate cancer suggest that early diagnosis and treatment for localized tumors may improve survival.1-2 In particular, in a randomized controlled trial from Scandinavia, Bill-Axelson et al3 demonstrated that patients with clinically detected, early stage prostate cancers who were assigned to radical prostatectomy had better survival than those assigned to watchful waiting.3 An important caveat is that the survival benefits of prostatectomy were concentrated among men younger than 65 years.3 Given that the frequently indolent nature of prostate cancer in older men,4-5 this finding begets clinical uncertainty regarding the role of initial local therapy in this population.

In this issue of JAMA, Wong and colleagues6 address this important gap in current knowledge with data from a well-designed and well-executed observational study. Specifically, the authors used population-based, linked data from the National . . . [Full Text of this Article]

Author Affiliations: Department of Urology, David Geffen School of Medicine (Drs Litwin and Miller); Department of Health Services, School of Public Health (Dr Litwin); Jonsson Comprehensive Cancer Center (Drs Litwin and Miller); University of California, Los Angeles.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Survival Associated With Treatment vs Observation of Localized Prostate Cancer in Elderly Men
Yu-Ning Wong, Nandita Mitra, Gary Hudes, Russell Localio, J. Sanford Schwartz, Fei Wan, Chantal Montagnet, and Katrina Armstrong
JAMA. 2006;296(22):2683-2693.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Outcomes of Treatment vs Observation of Localized Prostate Cancer in Elderly Men
Lu-Yao et al.
JAMA 2007;297:1651-1651.
FULL TEXT  

Therapy Options in Older Men with Prostate Cancer
JWatch Oncology and Hematology 2007;2007:2-2.
FULL TEXT  

Treatment vs. Observation in Older Men with Localized Prostate Cancer
JWatch General 2006;2006:1-1.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.